In a Methotrexate-Induced Model of Intestinal Mucositis, Olmesartan Reduced Inflammation and Induced Enteropathy Characterized by Severe Diarrhea, Weight Loss, and Reduced Sucrose Activity-Reference-Cited by-同舟云学术

In a Methotrexate-Induced Model of Intestinal Mucositis, Olmesartan Reduced Inflammation and Induced Enteropathy Characterized by Severe Diarrhea, Weight Loss, and Reduced Sucrose Activity

Published:2015 Issue:5 Volume:38 Page:746-752
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

de Araújo Aurigena Antunes¹,Borba Pedro Brito²,de Souza Fernando Henrique Destefani³,Nogueira Anália Cristina³,Saldanha Taís Suassuna³,Araújo Thayse Emanuele Franklin³,da Silva Aldemara Ingrid²,de Araújo Júnior Raimundo Fernandes⁴

Affiliation:

1. Department of Biophysics and Pharmacology, Federal University of Rio Grande Norte (UFRN), Post Graduation Program Public Health/Post Graduation Program in Pharmaceutical Science

2. Department of Biophysics and Pharmacology, UFRN

3. Department of Medicine, UFRN

4. Department of Morphology, Post Graduation Program Health Science/Post Graduation Program in Functional and Structural Biology, UFRN

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/38/5/38_b14-00847/_pdf

Reference27 articles.

1. 1) Alamir I, Boukhettala N, Aziz M, Breuille D, Dechelotte P, Coeffier M. Beneficial effects of cathepsin inhibition to prevent chemotherapy-induced intestinal mucositis. Clin. Exp. Immunol., 162, 298–305 (2010).

2. 2) Duncan M, Grant G. Oral and intestinal mucositis-causes and possible treatments. Aliment. Pharmacol. Ther., 18, 853–874 (2003).